Skip to main content
. 2019 Jan 30;10:31. doi: 10.3389/fendo.2019.00031

Table 2B.

Response to questions regarding therapy (Q11–Q17).

Percentage of Respondents Choosing Each Treatment Option
Question # Q11 Q12 Q13 Q14 Q15 Q16 Q17
Patient characteristics Sxs, request, thyX, TSH 2.2, T3 75 Sxs, request, prior LT3, TSH 2.2, T3 75 Sxs, request, male, TSH 2.2, T3 75 Sxs, request, polym, TSH 2.2, T3 75 Sxs, request, 59 yo, TSH 2.2, T3 75 Sxs, request, BMI 32, TSH 2.2, T3 75 Sxs, request, co-morb, TSH 2.2, T3 75
Treatment Options Feb
Continue LT4 27.71 25.40 31.73 15.60 39.36 28.80 47.20
Increase LT4 14.06 4.60 13.25 8.00 10.44 12.80 10.00
Add LT3, ↓LT4 31.33 42.80 30.92 40.80 34.14 30.40 30.00
Add LT3 to LT4 21.29 22.00 18.88 27.20 10.84 22.00 8.00
Switch to DTE 5.62 5.20 5.22 4.00 5.22 5.60 4.40
LT3 only 0.00 0.00 0.00 4.40 0.00 0.40 0.40
Treatment Options Mar
Continue LT4 28.95 27.43 30.70 18.58 38.94 31.58 46.49
Increase LT4 10.53 6.19 9.65 4.42 12.39 10.53 10.53
Add LT3, ↓LT4 33.33 38.05 38.60 43.36 31.86 34.21 28.07
Add LT3 to LT4 21.93 25.66 17.54 31.86 12.39 19.30 10.53
Switch to DTE 5.26 2.65 3.51 1.77 4.42 4.39 4.39
LT3 only 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Treatment Options Dec
Continue LT4 18.75 19.53 21.88 14.17 28.35 21.88 41.41
Increase LT4 17.19 6.25 13.28 2.36 10.24 15.63 7.81
Add LT3, ↓LT4 38.28 46.88 38.28 43.31 45.67 34.38 35.16
Add LT3 to LT4 24.22 27.34 25.00 37.80 14.17 26.56 13.28
Switch to DTE 1.56 0.00 1.56 1.57 1.57 1.56 2.34
LT3 only 0.00 0.00 0.00 0.79 0.00 0.00 0.00